Documento fuente o registro público
FDA 510(k) K231007 — CEDIA Heroin Metabolite (6-AM) Assay
FDA 510(k) index record K231007. Device: CEDIA Heroin Metabolite (6-AM) Assay. Applicant as listed: Microgenics Corporation. Decision date: 2023-09-27.
Fuente
"device_name": "CEDIA Heroin Metabolite (6-AM) Assay"
Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.
Review and references
Automated FDA record verification
2026-10-20
2026-10-28
professional use
FDA 510(k) public index record K231007.
Device name: CEDIA Heroin Metabolite (6-AM) Assay. Applicant as listed: Microgenics Corporation.
Decision date: 2023-09-27. Decision wording: Substantially Equivalent.
Product code: DJG. Regulation: 21 CFR 862.3650. Medical specialty: Clinical Toxicology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.